IRIS

Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i / Dummer, R; Lebbe, C; Atkinson, V; Mandala, M; Nathan, Pd; Arance, A; Richtig, E; Yamazaki, N; Robert, C; Schadendorf, D; Tawbi, Ha; Ascierto, P; Ribas, A; Flaherty, Kt; Pakhle, N; Campbell, Cd; Gusenleitner, D; Masood, A; Brase, Jc; Gasal, E; Long, Gv. - In: NATURE MEDICINE. - ISSN 1078-8956. - 26:10(2020), pp. 1557-+. [10.1038/s41591-020-1082-2]

Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i

Ascierto P;
2020
2020
NATURE MEDICINE
Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i / Dummer, R; Lebbe, C; Atkinson, V; Mandala, M; Nathan, Pd; Arance, A; Richtig, E; Yamazaki, N; Robert, C; Schadendorf, D; Tawbi, Ha; Ascierto, P; Ribas, A; Flaherty, Kt; Pakhle, N; Campbell, Cd; Gusenleitner, D; Masood, A; Brase, Jc; Gasal, E; Long, Gv. - In: NATURE MEDICINE. - ISSN 1078-8956. - 26:10(2020), pp. 1557-+. [10.1038/s41591-020-1082-2]
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1014054
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 97
  • ???jsp.display-item.citation.isi??? 96
social impact